Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.

C.B. Moelans; R.A. de Weger; H.N. Monsuur; A.H.J. Maes; P.J. van Diest

Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.

Translated title of the contribution: Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.

C.B. Moelans
, R.A. de Weger
, H.N. Monsuur
, A.H.J. Maes
, P.J. van Diest

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.
Original language	Undefined/Unknown
Pages (from-to)	475-482
Number of pages	8
Journal	Cellular oncology
Volume	34
Issue number	5
Publication status	Published - 2011

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/21547576

Cite this

@article{af1a07c4911b4375955a207cd166e79d,

title = "Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.",

author = "C.B. Moelans and \{de Weger\}, R.A. and H.N. Monsuur and A.H.J. Maes and \{van Diest\}, P.J.",

year = "2011",

language = "Undefined/Unknown",

volume = "34",

pages = "475--482",

journal = "Cellular oncology",

issn = "2211-3428",

publisher = "Springer Science and Business Media B.V.",

number = "5",

}

TY - JOUR

T1 - Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.

AU - Moelans, C.B.

AU - de Weger, R.A.

AU - Monsuur, H.N.

AU - Maes, A.H.J.

AU - van Diest, P.J.

PY - 2011

Y1 - 2011

M3 - Article

SN - 2211-3428

VL - 34

SP - 475

EP - 482

JO - Cellular oncology

JF - Cellular oncology

IS - 5

ER -